Key findings
SECONDARY
In this double-blind, randomized controlled trial the authors found that PCr administration to patients undergoing double/triple valve surgery under cardiopulmonary bypass was safe but not associated with a decrease in troponin I concentration nor in an improvement in any of the numerous secondary outcomes.